TOSYMRA

Product NDC: 67857-812
Requested package NDC: 67857-812-61
11-digit product format: 678570812
Labeler code: 67857
Product ID: 67857-812_cb524718-e675-acbc-5250-09a04d10c214
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: sumatriptan
Dosage form: SPRAY
Route: NASAL
Labeler: Promius Pharma, LLC.
Application: NDA210884
Marketing category: NDA
Marketing start: 2019-07-08
Marketing end: 0000-00-00
Substance: SUMATRIPTAN
Active strength: 10 mg/1
Pharmacologic classes: Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	67857-812	67857-812-61	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N210884-001	TOSYMRA	SUMATRIPTAN	10MG/SPRAY	SPRAY / NASAL		RLD, RS	2019-01-25

Orange Book patents#

Current patent rows page 1 of 1 · 9 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N210884-001	8268791	2026-05-09		Drug product	2019-02-21
N210884-001	8440631	2026-05-09	U-1719	Drug product	2019-02-21
N210884-001	9283280	2026-05-09		Drug product	2019-02-21
N210884-001	10603305	2030-06-16	U-1719	Drug product	2020-03-31
N210884-001	11337962	2030-06-16	U-1719	Drug product	2022-05-25
N210884-001	12090139	2030-06-16		Drug product	2024-10-17
N210884-001	9610280	2030-06-16	U-1719	Drug product	2019-02-21
N210884-001	9974770	2030-06-16	U-1719	Drug product	2019-02-21
N210884-001	9211282	2031-07-19	U-1719	Drug product	2019-02-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N210884-001	TOSYMRA	10MG/SPRAY	SPRAY / NASAL	RLD, RS	2019-01-25	`e64feba35796…`

Observed Orange Book patent history#

Patent history page 1 of 9 · 330 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210884-001	8268791	2026-05-09		Drug product	2019-02-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	8440631	2026-05-09	U-1719	Drug product	2019-02-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	9283280	2026-05-09		Drug product	2019-02-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	10603305	2030-06-16	U-1719	Drug product	2020-03-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	11337962	2030-06-16	U-1719	Drug product	2022-05-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	12090139	2030-06-16		Drug product	2024-10-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	9610280	2030-06-16	U-1719	Drug product	2019-02-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	9974770	2030-06-16	U-1719	Drug product	2019-02-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210884-001	9211282	2031-07-19	U-1719	Drug product	2019-02-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210884-001	8268791	2026-05-09		Drug product	2019-02-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	8440631	2026-05-09	U-1719	Drug product	2019-02-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	9283280	2026-05-09		Drug product	2019-02-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	10603305	2030-06-16	U-1719	Drug product	2020-03-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	11337962	2030-06-16	U-1719	Drug product	2022-05-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	12090139	2030-06-16		Drug product	2024-10-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	9610280	2030-06-16	U-1719	Drug product	2019-02-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	9974770	2030-06-16	U-1719	Drug product	2019-02-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210884-001	9211282	2031-07-19	U-1719	Drug product	2019-02-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	8268791	2026-05-09		Drug product	2019-02-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	8440631	2026-05-09	U-1719	Drug product	2019-02-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	9283280	2026-05-09		Drug product	2019-02-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	10603305	2030-06-16	U-1719	Drug product	2020-03-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	11337962	2030-06-16	U-1719	Drug product	2022-05-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	12090139	2030-06-16		Drug product	2024-10-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	9610280	2030-06-16	U-1719	Drug product	2019-02-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	9974770	2030-06-16	U-1719	Drug product	2019-02-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210884-001	9211282	2031-07-19	U-1719	Drug product	2019-02-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210884-001	8268791	2026-05-09		Drug product	2019-02-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	8440631	2026-05-09	U-1719	Drug product	2019-02-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	9283280	2026-05-09		Drug product	2019-02-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	10603305	2030-06-16	U-1719	Drug product	2020-03-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	11337962	2030-06-16	U-1719	Drug product	2022-05-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	12090139	2030-06-16		Drug product	2024-10-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	9610280	2030-06-16	U-1719	Drug product	2019-02-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	9974770	2030-06-16	U-1719	Drug product	2019-02-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210884-001	9211282	2031-07-19	U-1719	Drug product	2019-02-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210884-001	8268791	2026-05-09		Drug product	2019-02-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210884-001	8440631	2026-05-09	U-1719	Drug product	2019-02-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210884-001	9283280	2026-05-09		Drug product	2019-02-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210884-001	10603305	2030-06-16	U-1719	Drug product	2020-03-31	`fd3edfee7708…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
59adc2ba-d5f0-4a52-b35a-cc77921a79d2	Product name	4	20250724
4b7700e3-6e0e-45e5-9d22-6f754d61386e	Product name	2	20250304
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
2839c963-7eb3-970a-287f-ff1b6d381268	Product name	2	20250103
1e973b2d-e028-69cd-9258-4613ba80fdc5	Product name	3	20210512
3eb481d3-8b69-436f-82dd-4a66345568ab	Product name	1	20190611
e76dbbc1-775d-722c-08ff-ed45e8a80def	Product name	3	20181002
c100f0c7-e9dd-42f4-b0a8-0d81bd2a877c	Product name	1	20160303
49615343-b619-4365-8118-8f2ed6046e78	Product name	1	20160224
a6319377-430a-43db-82f9-30d1d9d89cf8	Product name	1	20151216
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508
f6199b09-e585-7ceb-4b09-803cf5ce1ed1	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
67857-812-61	2023-01-30	C162847	48780-1	f386c649-f925-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use TOSYMRA safely and effectively. See full prescribing information for TOSYMRA. TOSYMRA (sumatriptan) nasal spray Initial U.S. Approval: 1992

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
67857-812-61	TOSYMRA	6 in 1 CARTON	SPRAY	6	1
67857-812-62	TOSYMRA	0.1 in 1 VIAL, SINGLE-DOSE	SPRAY	0.1	1
67857-812-62	TOSYMRA	1 in 1 BLISTER PACK	SPRAY	1	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67857-812-61	EA - Each	67857-812	e152954d-1e9a-4cea-9149-b92e0842437c	1	2019-10-07
67857-812-62	EA - Each	67857-812	5201ae4e-8426-4b53-9040-0d17c65c6b6d	1	2019-10-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67857-812	TOSYMRA (SUMATRIPTAN) SPRAY [PROMIUS PHARMA, LLC.]	1	Legacy NDC, 3 package rows	20190708_7260d567-3824-230d-836d-8065302baaec.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tosymra	SUMATRIPTAN	Tonix Medicines, Inc.	d9f682f0-d50a-4fe6-ab1b-e5a7ec27b3a5	2025-02-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210884 application number: NDA210884
TOSYMRA	SUMATRIPTAN	Upsher-Smith Laboratories, LLC	015a5cf9-f246-48bc-b91e-cd730a53d8aa	2024-11-18	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210884 application number: NDA210884

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
8R78F6L9VO	SUMATRIPTAN	103628-46-2	SUMATRIPTAN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
401978	SUMAtriptan 10 MG/ACTUAT Nasal Spray	PSN	7260d567-3824-230d-836d-8065302baaec	1
2178073	tosymra 10 MG in 0.1 mL Nasal Spray	PSN	7260d567-3824-230d-836d-8065302baaec	1
2178073	sumatriptan 10 MG/ACTUAT Nasal Spray [Tosymra]	SBD	7260d567-3824-230d-836d-8065302baaec	1
401978	sumatriptan 10 MG/ACTUAT Nasal Spray	SCD	7260d567-3824-230d-836d-8065302baaec	1
401978	sumatriptan 10 MG/Spray Nasal Spray	SY	7260d567-3824-230d-836d-8065302baaec	1
2178073	Tosymra 10 MG/ACTUAT Nasal Spray	SY	7260d567-3824-230d-836d-8065302baaec	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
67857-812-61	67857081261	6 BLISTER PACK in 1 CARTON (67857-812-61) > 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK (67857-812-62) > .1 SPRAY in 1 VIAL, SINGLE-DOSE	6 blister pack	2019-07-08	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TOSYMRA	Promius Pharma, LLC. \| Dr. Reddy's Laboratories, Ltd. \| Renaissance Lakewood LLC \| Next Breath, a Division of AptarGroup \| SMS Pharmaceuticals Limited	2019-01-25	HUMAN PRESCRIPTION DRUG LABEL	1